265 related articles for article (PubMed ID: 33273174)
21. Diagnosis and current treatment of neurological paraneoplastic syndromes.
Molina-Garrido MJ; Guillén-Ponce C; Martínez S; Guirado-Risueño M
Clin Transl Oncol; 2006 Nov; 8(11):796-801. PubMed ID: 17134967
[TBL] [Abstract][Full Text] [Related]
22. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
23. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic neurological syndromes].
Stich O; Rauer S
Nervenarzt; 2013 Apr; 84(4):455-60. PubMed ID: 23443876
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic neurological syndromes: a practical approach to diagnosis and management.
Binks S; Uy C; Honnorat J; Irani SR
Pract Neurol; 2022 Feb; 22(1):19-31. PubMed ID: 34510016
[TBL] [Abstract][Full Text] [Related]
26. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
27. [Paraneoplastic Disorders of the Central Nervous System].
Kimura A
Brain Nerve; 2021 May; 73(5):620-630. PubMed ID: 34006696
[TBL] [Abstract][Full Text] [Related]
28. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy.
Zekeridou A; Lennon VA
Mayo Clin Proc; 2019 Sep; 94(9):1865-1878. PubMed ID: 31358366
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic neurologic autoimmune diseases].
Voltz R
Nervenarzt; 2002 Oct; 73(10):909-29. PubMed ID: 12376879
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic encephalomyelopathies: pathology and mechanisms.
McKeon A; Pittock SJ
Acta Neuropathol; 2011 Oct; 122(4):381-400. PubMed ID: 21938556
[TBL] [Abstract][Full Text] [Related]
31. Immune-mediated encephalopathies with an emphasis on paraneoplastic encephalopathies.
Pruitt AA
Semin Neurol; 2011 Apr; 31(2):158-68. PubMed ID: 21590621
[TBL] [Abstract][Full Text] [Related]
32. Neurological paraneoplastic syndromes: an update.
Berzero G; Psimaras D
Curr Opin Oncol; 2018 Nov; 30(6):359-367. PubMed ID: 30124520
[TBL] [Abstract][Full Text] [Related]
33. Advances in paraneoplastic neurological syndromes.
Honnorat J; Cartalat-Carel S
Curr Opin Oncol; 2004 Nov; 16(6):614-20. PubMed ID: 15627026
[TBL] [Abstract][Full Text] [Related]
34. Neurologic paraneoplastic syndromes.
Dropcho EJ
Curr Oncol Rep; 2004 Jan; 6(1):26-31. PubMed ID: 14664757
[TBL] [Abstract][Full Text] [Related]
35. Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery.
Segal Y; Zekeridou A
Curr Opin Neurol; 2024 Jun; 37(3):295-304. PubMed ID: 38533672
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment.
Chirra M; Marsili L; Gallerini S; Keeling EG; Marconi R; Colosimo C
Eur J Intern Med; 2019 Sep; 67():14-23. PubMed ID: 31200996
[TBL] [Abstract][Full Text] [Related]
37. Clinical approach to diagnosis of paraneoplastic neurologic syndromes.
Graus F
Handb Clin Neurol; 2024; 200():79-96. PubMed ID: 38494298
[TBL] [Abstract][Full Text] [Related]
38. Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
Jean MJ; Samkoff L; Mohile N
Curr Treat Options Oncol; 2024 Jan; 25(1):42-65. PubMed ID: 38198120
[TBL] [Abstract][Full Text] [Related]
39. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
40. Paraneoplastic neurological disorders.
Blaes F; Tschernatsch M
Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
